Vanda Pharmaceuticals Inc. (VNDA)

NASDAQ: VNDA · IEX Real-Time Price · USD
11.69
+0.19 (1.65%)
Jul 6, 2022 9:46 AM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 2004
Revenue
268.68248.17227.19193.12165.08146.02109.9350.1633.8832.73
Upgrade
Revenue Growth (YoY)
8.27%9.23%17.64%16.98%13.06%32.83%119.16%48.05%3.52%4.66%
Upgrade
Cost of Revenue
25.6323.3624.4920.5117.8524.7123.461.5800.13
Upgrade
Gross Profit
243.05224.8202.7172.61147.24121.3186.4648.5733.8832.6
Upgrade
Selling, General & Admin
124.05140.51129.74105.75123.8499.7984.5384.6425.0814.52
Upgrade
Research & Development
75.3655.5848.6543.5938.5529.1629.1519.2328.545.76
Upgrade
Other Operating Expenses
1.481.481.511.531.7510.9312.97-75.361.51.5
Upgrade
Operating Expenses
200.89197.57179.89150.87164.14139.88126.6528.5155.0861.78
Upgrade
Operating Income
42.1727.2422.8121.74-16.9-18.57-40.1920.06-21.2-29.18
Upgrade
Other Expense / Income
-0.2-4.42-6.22-3.61-1.47-0.67-0.32-0.12-0.15-0.56
Upgrade
Pretax Income
42.3631.6629.0325.35-15.43-17.91-39.8720.19-21.06-28.62
Upgrade
Income Tax
9.218.32-86.530.140.140.10000
Upgrade
Net Income
33.1523.34115.5525.21-15.57-18.01-39.8720.19-21.06-28.62
Upgrade
Net Income Common
33.1523.34115.5525.21-15.57-18.01-39.8720.19-21.06-28.62
Upgrade
Net Income Growth
42.06%-79.80%358.40%-------
Upgrade
Shares Outstanding (Basic)
56545351454342353028
Upgrade
Shares Outstanding (Diluted)
57555553454342373028
Upgrade
Shares Change
3.14%0.63%3.40%18.58%2.96%2.84%15.17%20.87%7.52%0.43%
Upgrade
EPS (Basic)
0.600.432.170.50-0.35-0.41-0.940.58-0.69-1.01
Upgrade
EPS (Diluted)
0.580.422.110.48-0.35-0.41-0.940.55-0.69-1.01
Upgrade
EPS Growth
38.09%-80.09%339.58%-------
Upgrade
Free Cash Flow Per Share
1.150.920.850.09-0.08-0.220.23-2.37-1.31-1.66
Upgrade
Gross Margin
90.46%90.59%89.22%89.38%89.19%83.08%78.66%96.84%100.00%99.61%
Upgrade
Operating Margin
15.69%10.98%10.04%11.26%-10.24%-12.72%-36.56%40.00%-62.58%-89.16%
Upgrade
Profit Margin
12.34%9.40%50.86%13.05%-9.43%-12.33%-36.27%40.25%-62.15%-87.44%
Upgrade
Free Cash Flow Margin
23.69%20.14%19.78%2.39%-2.21%-6.51%9.03%-164.13%-117.38%-143.41%
Upgrade
Effective Tax Rate
21.74%26.28%-298.07%0.54%-0.88%-0.58%0.00%0.00%0.00%0.00%
Upgrade
EBITDA
45.2134.5231.9228.3-12.45-6.04-26.3122.97-19.13-26.49
Upgrade
EBITDA Margin
16.83%13.91%14.05%14.66%-7.54%-4.13%-23.94%45.80%-56.46%-80.94%
Upgrade
Depreciation & Amortization
2.842.862.892.962.9811.8713.552.781.932.13
Upgrade
EBIT
42.3631.6629.0325.35-15.43-17.91-39.8720.19-21.06-28.62
Upgrade
EBIT Margin
15.77%12.75%12.78%13.13%-9.35%-12.26%-36.27%40.25%-62.15%-87.44%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).